Franchise Brands plc (LON:FRAN – Get Free Report) insider Nigel Wray purchased 50,000 shares of Franchise Brands stock in a transaction that occurred on Wednesday, October 15th. The stock was acquired at an average price of GBX 120 per share, with a total value of £60,000.
Franchise Brands Stock Performance
Shares of FRAN opened at GBX 118.30 on Thursday. The company has a debt-to-equity ratio of 42.67, a quick ratio of 1.57 and a current ratio of 1.39. The stock has a market capitalization of £227.65 million, a P/E ratio of 2,942.79 and a beta of 0.82. The company’s fifty day moving average is GBX 133.40 and its two-hundred day moving average is GBX 140.41. Franchise Brands plc has a 1 year low of GBX 117.50 and a 1 year high of GBX 185.
Franchise Brands (LON:FRAN – Get Free Report) last announced its quarterly earnings data on Wednesday, July 30th. The company reported GBX 4.42 earnings per share (EPS) for the quarter. Franchise Brands had a net margin of 6.43% and a return on equity of 3.60%. On average, sell-side analysts predict that Franchise Brands plc will post 11.3266098 earnings per share for the current year.
Franchise Brands Company Profile
Franchise Brands is an international, multi-brand franchisor focused on B2B van-based service with seven franchise brands and a presence in 10 countries across the UK, North America and Europe. The Group is focused on building market-leading businesses primarily via a franchise model and has a combined network of over 600 franchisees.
The Company owns several market-leading brands with long trading histories, including Pirtek in Europe, Filta, Metro Rod and Metro Plumb, all of which benefit from the Group’s central support services, particularly technology, marketing, and finance.
Recommended Stories
- Five stocks we like better than Franchise Brands
- CD Calculator: Certificate of Deposit Calculator
- Palantir’s New Healthcare Deal Boosts AI and Data Reach
- 3 Tickers Leading a Meme Stock Revival
- GM’s Billion-Dollar Bruise: GM’s Strategic Pivot Makes It a Buy
- Asset Allocation Strategies in Volatile Markets
- Novo Nordisk’s Akero Therapeutics Buy Targets Eli Lilly’s Lead
Receive News & Ratings for Franchise Brands Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Franchise Brands and related companies with MarketBeat.com's FREE daily email newsletter.